AG˹ٷ

STOCK TITAN

Neogen® Establishes Relationship with Biomatter

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

LANSING, Mich.--(BUSINESS WIRE)-- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that it has entered into an arrangement with Biomatter, a leading enzyme design company, to leverage Biomatter’s proprietary Intelligent Architecture� platform and Neogen’s expertise in the field of analytical development and technology to create new enzyme-based products.

Biomatter’s Intelligent Architecture� platform, based on AI and Physical modelling, enables the design of enzymes with unique capabilities, dramatically expanding how they can be used in food safety related applications.

“This relationship marks a significant step forward in advancing food security,� said Dr. Jason Lilly, Neogen’s Chief Scientific Officer. “By combining our leadership and innovation in food testing and risk mitigation with Biomatter’s cutting-edge enzyme engineering capabilities, we’re unlocking new possibilities that can enhance detection, improve efficiency, and ultimately protect and enhance the quality and safety of the global food supply.�

“It is a privilege to partner with Neogen to create new enzymes that will push the boundaries of food and animal safety solutions,� said Laurynas Karpus, Biomatter’s Chief Executive Officer. “Together, our teams aim to set new standards in the industry, making every step of the process more efficient, cost-effective, and ultimately more beneficial for the end user.�

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

About Biomatter

Biomatter is a next-generation enzyme design company breaking the limits of traditional protein engineering. Leveraging its generative AI-powered Intelligent Architecture� platform, the company designs novel, high-performance enzymes from the ground up. Through collaborations with industry leaders in medicine, diagnostics, agriculture, and biomanufacturing, Biomatter delivers unique enzymatic solutions that enable differentiated products and promote a healthier, more sustainable world. Discover more at .

[email protected]

[email protected]

Source: Neogen® Corporation

Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.04B
215.75M
0.38%
116.85%
8.43%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
United States
LANSING